- Home
- RADX vs TACT Comparison
RADX vs TACT Comparison
Compare RADX & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- TACT
- Stock Information
- Founded
- RADX 2021
- TACT 1996
- Country
- RADX Australia
- TACT United States
- Employees
- RADX N/A
- TACT N/A
- Industry
- RADX
- TACT Computer peripheral equipment
- Sector
- RADX
- TACT Technology
- Exchange
- RADX NYSE
- TACT Nasdaq
- Market Cap
- RADX 32.5M
- TACT 35.7M
- IPO Year
- RADX N/A
- TACT 1996
- Fundamental
- Price
- RADX $4.25
- TACT $3.85
- Analyst Decision
- RADX Strong Buy
- TACT Strong Buy
- Analyst Count
- RADX 2
- TACT 1
- Target Price
- RADX $13.50
- TACT $5.00
- AVG Volume (30 Days)
- RADX 22.4K
- TACT 13.8K
- Earning Date
- RADX 02-26-2025
- TACT 08-07-2025
- Dividend Yield
- RADX N/A
- TACT N/A
- EPS Growth
- RADX N/A
- TACT N/A
- EPS
- RADX N/A
- TACT N/A
- Revenue
- RADX $204,609.00
- TACT $45,750,000.00
- Revenue This Year
- RADX N/A
- TACT $14.81
- Revenue Next Year
- RADX N/A
- TACT N/A
- P/E Ratio
- RADX N/A
- TACT N/A
- Revenue Growth
- RADX N/A
- TACT N/A
- 52 Week Low
- RADX $3.50
- TACT $3.12
- 52 Week High
- RADX $50.82
- TACT $5.11
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- TACT 59.80
- Support Level
- RADX N/A
- TACT $3.49
- Resistance Level
- RADX N/A
- TACT $3.83
- Average True Range (ATR)
- RADX 0.00
- TACT 0.22
- MACD
- RADX 0.00
- TACT 0.03
- Stochastic Oscillator
- RADX 0.00
- TACT 72.22
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.